Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AdaptHealth Corp.AHCO · Entity 5183 | Director | August 06, 2026 | August 14, 2026 |
| MOLINA HEALTHCARE, INC.MOH · Entity 3504 | Director | October 01, 2026 | October 03, 2026 |
| eHealth, Inc.EHTH · Entity 497 | Director | June 18, 2026 | June 23, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AdaptHealth Corp.
Report date August 06, 2026 · Filed August 14, 2026 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 143,234 |
Reported balance
After 2026-08-06 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2026-08-06 · Purchase · Acquired 20,000 · Balance 143,234 F1: The Form 4 originally filed on August 10, 2026 is being amended to report the correct pricing of the shares purchased by the Reporting Person. These shares were purchased in multiple transactions at prices ranging from $6.26 to $6.335, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1). |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 34,000 |
Reported balance
Holding disclosure · report date 2026-08-06 · row 2
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 2 · Balance 34,000 F2: Securities held by the Dale B. Wolf Generation Skipping Trust (the "GST"). The reporting person is the investment manager of the GST. |
Filing footnotes · ownership attribution and instrument terms
F1: The Form 4 originally filed on August 10, 2026 is being amended to report the correct pricing of the shares purchased by the Reporting Person. These shares were purchased in multiple transactions at prices ranging from $6.26 to $6.335, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1).
F2: Securities held by the Dale B. Wolf Generation Skipping Trust (the "GST"). The reporting person is the investment manager of the GST.
MOLINA HEALTHCARE, INC.
Report date October 01, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectHeld by Trust | 15,937 |
Reported balance
After 2026-10-01 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2026-10-01 · Grant · Acquired 304 · Balance 15,937 F1: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2026 was $180.85, which resulted in a grant of 304 shares. F3: Represents the closing price of the Issuer's common stock on October 1, 2026. F4: Shares are held by Dale B. Wolf Revocable Trust, of which Dale B. Wolf is the sole trustee. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.
F2: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2026 was $180.85, which resulted in a grant of 304 shares.
F3: Represents the closing price of the Issuer's common stock on October 1, 2026.
F4: Shares are held by Dale B. Wolf Revocable Trust, of which Dale B. Wolf is the sole trustee.
eHealth, Inc.
Report date June 18, 2026 · Filed June 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 184,174 |
Reported balance
After 2026-06-18 transaction · row 1
1 source rowRow 1 · 2026-06-18 · Grant · Acquired 61,041 · Balance 184,174 F1: This represents an annual award of restricted stock units ("RSUs") to the Issuer's non-employee directors. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting. The RSUs vest in four equal quarterly installments from the vesting commencement date of June 18, 2026, subject to the individual's continued status as a Service Provider (as defined in the Issuer's Amended and Restated 2024 Equity Incentive Plan (the "Plan")) through the applicable vesting date; provided, however, that any then-unvested RSUs shall vest in full (i) on the day immediately prior to the date of the Issuer's next annual stockholder meeting or (ii) if the Issuer is subject to a Change in Control (as defined in the Plan), subject in each case to the individual's continued status as a Service Provider through such vesting date. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 62,932 |
Reported balance
Holding disclosure · report date 2026-06-18 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 62,932 F2: Shares held by the Dale B. Wolf Generation Skipping Trust. |
Filing footnotes · ownership attribution and instrument terms
F1: This represents an annual award of restricted stock units ("RSUs") to the Issuer's non-employee directors. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting. The RSUs vest in four equal quarterly installments from the vesting commencement date of June 18, 2026, subject to the individual's continued status as a Service Provider (as defined in the Issuer's Amended and Restated 2024 Equity Incentive Plan (the "Plan")) through the applicable vesting date; provided, however, that any then-unvested RSUs shall vest in full (i) on the day immediately prior to the date of the Issuer's next annual stockholder meeting or (ii) if the Issuer is subject to a Change in Control (as defined in the Plan), subject in each case to the individual's continued status as a Service Provider through such vesting date.
F2: Shares held by the Dale B. Wolf Generation Skipping Trust.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 07, 2018 Filed Aug 10, 2018 00:05 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 3,000 | $126.63 | $379,890.00 |
DisclosureSEC source: 0001179929-18-000157 · wf-form4_153385953926547.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,843 F1 · price: Represents the actual selling price per share of all 3,000 shares. Read SEC document |
| July 01, 2018 Filed Jul 3, 2018 23:02 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 562 | $97.94 | $55,042.28 |
DisclosureSEC source: 0001179929-18-000133 · wf-form4_153065892857066.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,843 F1 · kind: Grant of stock under the Issuer's 2011 Equity Incentive Plan, as amended, in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director in 2018-2019 shall be $220,000, with one quarter of that amount in stock, or $55,000, to be granted on the first day of each quarter based on the closing price of the Issuer's common stock on such day. Since the grant date of July 1, 2018 was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on June 29, 2018, of $97.94. Thus, the grant this quarter for services as a Director is for 562 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on June 29, 2018. Read SEC document |
| April 01, 2018 Filed Apr 4, 2018 00:19 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 678 | $81.18 | $55,040.04 |
DisclosureSEC source: 0001179929-18-000094 · wf-form4_152280112188601.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,281 F1 · kind: Grant of stock under the Issuer's 2011 Equity Incentive Plan, as amended, in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director in 2017-2018 shall be $220,000, with one quarter of that amount in stock, or $55,000, to be granted on the first day of each quarter based on the closing price of the Issuer's common stock on such day. Since the grant date of April 1, 2018 was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on March 29, 2018, of $81.18. Thus, the grant this quarter for services as a Director is for 678 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on March 29, 2018. Read SEC document |
| January 01, 2018 Filed Jan 3, 2018 01:11 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 717 | $76.68 | $54,979.56 |
DisclosureSEC source: 0001179929-18-000015 · wf-form4_151494185194979.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,603 F1 · kind: Grant of stock under the Issuer's 2011 Equity Incentive Plan, as amended, in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director in 2017-2018 shall be $220,000, with one quarter of that amount in stock, or $55,000, to be granted on the first day of each quarter based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2018 was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 29, 2017, of $76.68. Thus, the grant this quarter for services as a Director is for 717 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on December 29, 2017. Read SEC document |
| November 07, 2017 Filed Nov 7, 2017 23:39 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 5,000 | $77.46 | $387,305.50 |
DisclosureSEC source: 0001179929-17-000225 · wf-form4_151009793392235.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,886 F1 · price: Represents the weighted average share price of all purchases on the Transaction Date. The range of prices for the transactions was $77.44 to $77.467. Read SEC document |
| October 01, 2017 Filed Oct 2, 2017 22:32 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 800 | $68.76 | $55,008.00 |
DisclosureSEC source: 0001179929-17-000198 · wf-form4_150698351704657.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,886 F1 · kind: Grant of stock under the Issuer's 2011 Equity Incentive Plan, as amended, in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director in 2017-2018 shall be $220,000, with one quarter of that amount in stock, or $55,000, to be granted on the first day of each quarter based on the closing price of the Issuer's common stock on such day. Since the grant date of October 1, 2017 was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on September 29, 2017, of $68.76. Thus, the grant this quarter for services as a Director is for 800 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on September 29, 2017. Read SEC document |
| July 01, 2017 Filed Jul 5, 2017 21:47 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 795 | $69.18 | $54,998.10 |
DisclosureSEC source: 0001179929-17-000153 · wf-form4_149929124804625.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,086 F1 · kind: Grant of stock under the Issuer's 2011 Equity Incentive Plan, as amended, in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director in 2017-2018 shall be $220,000, with one quarter of that amount in stock, or $55,000, to be granted on the first day of each quarter based on the closing price of the Issuer's common stock on such day. Since the grant date of July 1, 2017 was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on June 30, 2017, of $69.18. Thus, the grant this quarter for services as a Director is for 795 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on June 30, 2017. Read SEC document |
| April 01, 2017 Filed Apr 4, 2017 20:58 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 1,206 | $45.60 | $54,993.60 |
DisclosureSEC source: 0001179929-17-000090 · wf-form4_149133948830513.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,291 F1 · kind: Grant of stock under the Issuer's 2011 Equity Incentive Plan in connection with the Reporting Person's services as a Director F2 · shares: The aggregate dollar value of the annual equity award to each director in 2016-2017 shall be $220,000, with one quarter of that amount in stock, or $55,000, to be granted on the first day of each quarter based on the closing price of the Issuer's common stock on such day. Since the grant date of April 1, 2017 was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on March 31, 2017, of $45.60. Thus, the grant this quarter for services as a director is for 1,206 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on March 31, 2017. Read SEC document |
| January 01, 2017 Filed Jan 4, 2017 00:54 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 1,014 | $54.26 | $55,019.64 |
DisclosureSEC source: 0001179929-17-000023 · wf-form4_148349127553636.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,085 F1 · kind: Grant of stock under the Issuer's 2011 Equity Incentive Plan in connection with the Reporting Person's services as a Director F2 · shares: The aggregate dollar value of the annual equity award to each director in 2016-2017 shall be $220,000, with one quarter of that amount in stock, or $55,000, to be granted on the first day of each quarter based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2017 was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 30, 2016, of $54.26. Thus, the grant this quarter for services as a director is for 1,014 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on December 30, 2016. Read SEC document |
| November 07, 2016 Filed Nov 9, 2016 00:25 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 3,000 | $57.63 | $172,890.00 |
DisclosureSEC source: 0001179929-16-000400 · wf-form4_147865113154623.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,071 F1 · price: Represents the weighted average share price of all purchases on the Transaction Date. The range of prices for the transactions was $57.62 to $57.65. The Reporting Person undertakes to provide full information to the Commission upon request. Read SEC document |
| October 01, 2016 Filed Oct 4, 2016 00:21 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 943 | $58.32 | $54,995.76 |
DisclosureSEC source: 0001179929-16-000387 · wf-form4_147554048925282.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,071 F1 · kind: Grant of stock under the Issuer's 2011 Equity Incentive Plan in connection with the Reporting Person's services as a director. F2 · shares: The aggregate dollar value of the annual equity award to each director in 2016-2017 shall be $220,000, with one quarter of that amount in stock, or $55,000, to be granted on the first day of each quarter based on the closing price of the Issuer's common stock on such day. Since the grant date of October 1, 2016 was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on September 30, 2016, of $58.32. Thus, the grant this quarter for services as a director is for 943 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on September 30, 2016. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.